Press Releases

Press Releases

Jul 28, 2020
Twist Bioscience Launches Two SARS-CoV-2 Antibody Panels to Expedite Research for COVID-19
Jul 23, 2020
Twist Bioscience Appoints Erin Smith Senior Vice President, Government Affairs and Public Policy
Jul 22, 2020
Twist Bioscience Launches Synthetic Controls for Respiratory Viruses
Jul 16, 2020
Twist Bioscience Partners with Invetx to Deliver Best-in-Class Antibody Therapeutics for Dogs and Cats
Jul 15, 2020
Twist Bioscience Customer Vanderbilt University Medical Center (VUMC) Announces Publication of Positive Preclinical Results on Neutralizing Antibodies as a Potential Therapy for Preventing and Treating COVID-19
Jul 08, 2020
Takeda Partners with Twist Bioscience to Expand Biologics Discovery Capabilities
Jun 30, 2020
Twist Bioscience Adds Respiratory Virus Panel to Infectious Disease Product Line
Jun 11, 2020
Twist Bioscience Expands Offering of Synthetic SARS-CoV-2 RNA Controls
Jun 08, 2020
Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jun 03, 2020
Twist Bioscience Announces Pricing of a $100 Million Public Offering of Common Stock